[1] |
Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, CMA; Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, CMA. Guideline for diagnosis and treatment of liver failure[J]. J Clin Hepatol, 2019, 35(1): 38-44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.
中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2018年版)[J]. 临床肝胆病杂志, 2019, 35(1): 38-44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.
|
[2] |
TUJIOS SR, HYNAN LS, VAZQUEZ MA, et al. Risk factors and outcomes of acute kidney injury in patients with acute liver failure[J]. Clin Gastroenterol Hepatol, 2015, 13(2): 352-359. DOI: 10.1016/j.cgh.2014.07.011.
|
[3] |
ANGELI P, GINES P, WONG F, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites[J]. Gut, 2015, 64(4): 531-537. DOI: 10.1136/gutjnl-2014-308874.
|
[4] |
KAMATH PS, WIESNER RH, MALINCHOC M, et al. A model to predict survival in patients with end-stage liver disease[J]. Hepatology, 2001, 33(2): 464-470. DOI: 10.1053/jhep.2001.22172.
|
[5] |
CHEN J, LIU XY, TONG JJ, et al. Clinical features of patients with acute/subacute liver failure complicated by acute kidney injury[J]. J Clin Hepatol, 2018, 34(2): 364-367. DOI: 10.3969/j.issn.1001-5256.2018.02.029.
陈婧, 刘晓燕, 童晶晶, 等. 急性/亚急性肝衰竭合并急性肾损伤的临床特征分析[J]. 临床肝胆病杂志, 2018, 34(2): 364-367. DOI: 10.3969/j.issn.1001-5256.2018.02.029.
|
[6] |
MOU YD, ZHANG LL, ZHANG PR. New advances in the study of early biological markers of acute kidney injury[J/CD]. Chin J Care Med(Electronic Edition), 2015, 8(3): 191-196. DOI:
牟迎东, 张琳琳, 张培荣. 急性肾损伤早期生物学标志物研究的新进展[J/CD]. 中华危重症医学杂志(电子版), 2015, 8(3): 191-196. DOI:
|
[7] |
de SEIGNEUX S, MARTIN PY. Preventing the progression of AKI to CKD: The role of mitochondria[J]. J Am Soc Nephrol, 2017, 28(5): 1327-1329. DOI: 10.1681/ASN.2017020146.
|
[8] |
WADEI HM. Hepatorenal syndrome: a critical update[J]. Semin Respir Crit Care Med, 2012, 33(1): 55-69. DOI: 10.1055/s-0032-1301735.
|
[9] |
SHI X, ZHU P, YAN G, et al. Clinical characteristics and long-term outcome of acute kidney injury in patients with HBV-related acute-on-chronic liver failure[J]. J Viral Hepat, 2016, 23(11): 920-929. DOI: 10.1111/jvh.12566.
|
[10] |
HAN SS, AHN SY, RYU J, et al. U-shape relationship of white blood cells with acute kidney injury and mortality in critically ill patients[J]. Tohoku J Exp Med, 2014, 232(3): 177-185. DOI: 10.1620/tjem.232.177.
|
[11] |
PIERI G, AGARWAL B, BURROUGHS AK. C-reactive protein and bacterial infection in cirrhosis[J]. Ann Gastroenterol, 2014, 27(2): 113-120.
|
[12] |
LUO Y, LU JJ, WANG YD, et al. The change of procalcitonin in patients with liver failure and its clinical application value[J]. Chin J Infect Dis, 2021, 39(7): 449-452. DOI: 10.3760/cma.j.cn311365-20200819-00760.
罗越, 逯晶晶, 王亚东, 等. 肝衰竭患者降钙素原的变化规律及其临床应用价值[J]. 中华传染病杂志, 2021, 39(7): 449-452. DOI: 10.3760/cma.j.cn311365-20200819-00760.
|
[13] |
KAN WC, HUANG YT, WU VC, et al. Predictive ability of procalcitonin for acute kidney injury: a narrative review focusing on the interference of infection[J]. Int J Mol Sci, 2021, 22(13). DOI: 10.3390/ijms22136903.
|
[14] |
NIE X, TANG JT, CAI B, et al. Analysis of procalcitonin in patients with end stage liver disease complicated with acute kidney injury[J]. Chin J Lab Med, 2013, 36(11): 1018-1021. DOI: 10.3760/cma.j.issn.1009-9158.2013.11.012.
聂鑫, 唐江涛, 蔡蓓, 等. 终末期肝衰竭伴急性肾损伤患者血清降钙素原水平研究[J]. 中华检验医学杂志, 2013, 36(11): 1018-1021. DOI: 10.3760/cma.j.issn.1009-9158.2013.11.012.
|
[15] |
HUANG ZL, GAO ZL. Triple blows and treatment strategies for liver failure[J]. J Intern Intensive Med, 2014, 20(3): 154-156. DOI: 10.11768/nkjwzzzz20140304.
黄湛镰, 高志良. 肝衰竭的三重打击及治疗策略[J]. 内科急危重症杂志, 2014, 20(3): 154-156. DOI: 10.11768/nkjwzzzz20140304.
|
[16] |
HUANG Z, LIN C, FANG J, et al. Acute kidney injury in hepatitis B-related acute-on-chronic liver failure without preexisting liver cirrhosis[J]. Hepatol Int, 2015, 9(3): 416-423. DOI: 10.1007/s12072-015-9636-y.
|
[17] |
HU H, HUANG BB, NING L, et al. Establishment and evaluation of a predictive model for short-time prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure[J]. J Clin Hepatol, 2020, 36(1): 123-127. DOI: 10.3969/j.issn.1001-5256.2020.01.027.
胡辉, 黄贝贝, 宁玲, 等. HBV相关慢加急性肝衰竭患者短期预后预测模型的建立与评价[J]. 临床肝胆病杂志, 2020, 36(1): 123-127. DOI: 10.3969/j.issn.1001-5256.2020.01.027.
|
[18] |
WU ZP, ZHONG YB, LI XP, et al. The analysis of acute kidney injury in hepatitis B virus related acute-on-chronic liver failure[J]. Chin J Infect Dis, 2016, 34(12): 713-716. DOI: 10.3760/cma.j.issn.1000-6680.2016.12.003.
吴振平, 钟渊斌, 李小鹏, 等. 乙型肝炎病毒相关慢加急性(亚急性)肝功能衰竭患者中急性肾损伤的分析[J]. 中华传染病杂志, 2016, 34(12): 713-716. DOI: 10.3760/cma.j.issn.1000-6680.2016.12.003.
|
[19] |
ZHANG ZQ, YE YN, HE G, et al. Study of risk factors and high-risk population of acute kidney injury in patients with hepatitis B virus related acute on chronic liver failure[J]. Chin Hepatol, 2019, 24(9): 997-1001, 1006. DOI: 10.3969/j.issn.1008-1704.2019.09.008.
张志侨, 叶一农, 何纲, 等. 乙型肝炎相关慢加急性肝衰竭患者急性肾损伤的影响因素和高危人群分析[J]. 肝脏, 2019, 24(9): 997-1001, 1006. DOI: 10.3969/j.issn.1008-1704.2019.09.008.
|
[20] |
YUAN W, ZHANG YY, ZHANG ZG, et al. Risk factors and outcomes of acute kidney injury in patients with hepatitis B virus-related acute-on-chronic liver failure[J]. Am J Med Sci, 2017, 353(5): 452-458. DOI: 10.1016/j.amjms.2017.03.005.
|